Royal Bank of Canada’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.12M | Sell |
20,245
-1,932
| -9% | -$92K | ﹤0.01% | 3538 |
|
|
2025
Q4 | $829K | Sell |
22,177
-25,557
| -54% | -$1.04M | ﹤0.01% | 3797 |
|
|
2025
Q3 | $1.93M | Buy |
47,734
+1,136
| +2% | +$37.5K | ﹤0.01% | 3436 |
|
|
2025
Q2 | $1.19M | Buy |
46,598
+39,527
| +559% | +$862K | ﹤0.01% | 3747 |
|
|
2025
Q1 | $151K | Sell |
7,071
-2,237
| -24% | -$50K | ﹤0.01% | 4913 |
|
|
2024
Q4 | $195K | Sell |
9,308
-108
| -1% | -$2.5K | ﹤0.01% | 4836 |
|
|
2024
Q3 | $212K | Buy |
9,416
+184
| +2% | +$3.55K | ﹤0.01% | 4772 |
|
|
2024
Q2 | $155K | Buy |
9,232
+1,574
| +21% | +$25.3K | ﹤0.01% | 4965 |
|
|
2024
Q1 | $99K | Sell |
7,658
-6,131
| -44% | -$73.5K | ﹤0.01% | 5191 |
|
|
2023
Q4 | $161K | Buy |
13,789
+3,304
| +32% | +$37.3K | ﹤0.01% | 5272 |
|
|
2023
Q3 | $135K | Buy |
10,485
+1,297
| +14% | +$18.4K | ﹤0.01% | 5146 |
|
|
2023
Q2 | $127K | Buy |
9,188
+745
| +9% | +$10.7K | ﹤0.01% | 5138 |
|
|
2023
Q1 | $129K | Sell |
8,443
-1,940
| -19% | -$29.6K | ﹤0.01% | 4972 |
|
|
2022
Q4 | $140K | Buy |
10,383
+10,007
| +2,661% | +$134K | ﹤0.01% | 5195 |
|
|
2022
Q3 | $5K | Sell |
376
-1,991
| -84% | -$34.4K | ﹤0.01% | 6741 |
|
|
2022
Q2 | $45K | Sell |
2,367
-1,208
| -34% | -$22.9K | ﹤0.01% | 5758 |
|
|
2022
Q1 | $71K | Sell |
3,575
-2,183
| -38% | -$44.1K | ﹤0.01% | 5863 |
|
|
2021
Q4 | $117K | Sell |
5,758
-19,969
| -78% | -$426K | ﹤0.01% | 5820 |
|
|
2021
Q3 | $554K | Buy |
25,727
+529
| +2% | +$12.7K | ﹤0.01% | 4252 |
|
|
2021
Q2 | $727K | Sell |
25,198
-4,467
| -15% | -$121K | ﹤0.01% | 3940 |
|
|
2021
Q1 | $723K | Sell |
29,665
-8,523
| -22% | -$193K | ﹤0.01% | 3874 |
|
|
2020
Q4 | $742K | Sell |
38,188
-4,045
| -10% | -$74.4K | ﹤0.01% | 3782 |
|
|
2020
Q3 | $735K | Sell |
42,233
-221
| -0.5% | -$4.72K | ﹤0.01% | 3517 |
|
|
2020
Q2 | $1.12M | Sell |
42,454
-1,716
| -4% | -$42.6K | ﹤0.01% | 3081 |
|
|
2020
Q1 | $1.07M | Buy |
44,170
+11,808
| +36% | +$289K | ﹤0.01% | 2976 |
|
|
2019
Q4 | $803K | Buy |
32,362
+3,906
| +14% | +$90.7K | ﹤0.01% | 3625 |
|
|
2019
Q3 | $607K | Buy |
28,456
+19,431
| +215% | +$532K | ﹤0.01% | 3715 |
|
|
2019
Q2 | $287K | Buy |
9,025
+8,022
| +800% | +$252K | ﹤0.01% | 4240 |
|
|
2019
Q1 | $33K | Buy |
1,003
+35
| +4% | +$1.09K | ﹤0.01% | 5393 |
|
|
2018
Q4 | $31K | Buy |
968
+199
| +26% | +$7.51K | ﹤0.01% | 5365 |
|
|
2018
Q3 | $32K | Sell |
769
-3,079
| -80% | -$145K | ﹤0.01% | 5447 |
|
|
2018
Q2 | $178K | Buy |
3,848
+34
| +0.9% | +$1.5K | ﹤0.01% | 4481 |
|
|
2018
Q1 | $151K | Buy |
3,814
+3,641
| +2,105% | +$135K | ﹤0.01% | 4474 |
|
|
2017
Q4 | $6K | Sell |
173
-1,501
| -90% | -$53.3K | ﹤0.01% | 6039 |
|
|
2017
Q3 | $62K | Buy |
1,674
+1,528
| +1,047% | +$57.4K | ﹤0.01% | 5294 |
|
|
2017
Q2 | $5K | Buy |
146
+118
| +421% | +$3.85K | ﹤0.01% | 6048 |
|
|
2017
Q1 | $1K | Sell |
28
-1,021
| -97% | -$28.8K | ﹤0.01% | 6521 |
|
|
2016
Q4 | $31K | Buy |
1,049
+142
| +16% | +$3.88K | ﹤0.01% | 5526 |
|
|
2016
Q3 | $25K | Buy |
907
+172
| +23% | +$3.89K | ﹤0.01% | 5463 |
|
|
2016
Q2 | $14K | Sell |
735
-13,318
| -95% | -$278K | ﹤0.01% | 5634 |
|
|
2016
Q1 | $380K | Buy |
14,053
+13,621
| +3,153% | +$391K | ﹤0.01% | 3879 |
|
|
2015
Q4 | $13K | Sell |
432
-644
| -60% | -$20.7K | ﹤0.01% | 5882 |
|
|
2015
Q3 | $34K | Buy |
1,076
+279
| +35% | +$10.2K | ﹤0.01% | 5331 |
|
|
2015
Q2 | $31K | Buy |
797
+400
| +101% | +$13.8K | ﹤0.01% | 5471 |
|
|
2015
Q1 | $14K | Sell |
397
-4,103
| -91% | -$132K | ﹤0.01% | 5471 |
|
|
2014
Q4 | $142K | Sell |
4,500
-23,200
| -84% | -$642K | ﹤0.01% | 4554 |
|
|
2014
Q3 | $621K | Buy |
+27,700
| New | +$555K | ﹤0.01% | 3259 |
|
Other funds holding PAHC
VCM
VPM
N
Royal Bank of Canada's PAHC Position: Q1 2026 in Review
Royal Bank of Canada reduced its Phibro Animal Health (PAHC) stake by 8.7% in Q1 2026, selling an estimated $92K and leaving 20,245 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3538.
Royal Bank of Canada first reported a position in PAHC in Q3 2014 and has held it in 47 quarters since. The position peaked at $1.93M in Q3 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.
- Royal Bank of Canada held 20,245 shares of Phibro Animal Health worth $1.12M as of Q1 2026.
- Royal Bank of Canada sold 1,932 Phibro Animal Health shares in Q1 2026, an estimated $92K.
- Phibro Animal Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3538 holding.
- Royal Bank of Canada first reported a position in Phibro Animal Health in Q3 2014 and has held it in 47 quarters since.
- Royal Bank of Canada's Phibro Animal Health position peaked at $1.93M in Q3 2025.
- 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.